Premenstrual dysphoric disorder (PMDD) is a condition in which a woman has severe depression symptoms, irritability, and tension before menstruation. The symptoms of PMDD are more severe than those seen with premenstrual syndrome (PMS).
PMS refers to a wide range of physical or emotional symptoms that most often occur about 5 to 11 days before a woman starts her monthly menstrual cycle. In most cases, the symptoms stop when, or shortly after, her period begins.
The causes of PMS and PMDD have not been found.
Hormone changes that occur during a woman's menstrual cycle may play a role.
PMDD affects a small number of women during the years when they are having menstrual periods.
Many women with this condition have:
Other factors that may play a role include:
- Alcohol or substance abuse
- Thyroid disorders
- Being overweight
- Having a mother with a history of the disorder
- Lack of exercise
The symptoms of PMDD are similar to those of PMS. However, they are very often more severe and debilitating. They also include at least one mood-related symptom. Symptoms occur during the week just before menstrual bleeding. They most often get better within a few days after the period starts.
Here is a list of common PMDD symptoms:
- Lack of interest in daily activities and relationships
- Fatigue or low energy
- Sadness or hopelessness, possibly thoughts of suicide
- Out of control feeling
- Food cravings or binge eating
- Mood swings sometimes with bouts of crying
- Panic attacks
- Irritability or anger that affects other people
- Bloating, breast tenderness, headaches, and joint or muscle pain
- Problems sleeping
- Trouble concentrating
Exams and Tests
No physical exam or lab tests can diagnose PMDD. A complete history, physical exam (including a pelvic exam), thyroid testing, and psychiatric evaluation should be done to rule out other conditions.
Keeping a calendar or diary of symptoms can help women identify the most troublesome symptoms and the times when they are likely to occur. This information may help your health care provider diagnose PMDD and determine the best treatment.
A healthy lifestyle is the first step to managing PMDD.
- Eat healthy foods with whole grains, vegetables, fruit, and little or no salt, sugar, alcohol, and caffeine.
- Get regular aerobic exercise throughout the month to reduce the severity of PMS symptoms.
- If you have problems sleeping, try changing your sleep habits before taking medicines for insomnia.
Keep a diary or calendar to record:
- The type of symptoms you are having
- How severe they are
- How long they last
Some antidepressants may be helpful.
The first option is most often an antidepressant known as a selective serotonin-reuptake inhibitor (SSRI). You can take SSRIs in the second part of your cycle up until your period starts. You may also take it the whole month. Ask your provider.
Cognitive behavioral therapy (CBT) may be used either with or instead of antidepressants. During CBT, you have about 10 visits with a mental health professional over several weeks to months.
Other treatments that may help include:
- Birth control pills which typically help reduce PMS symptoms. Continuous dosing types are most effective, especially those that contain a hormone called drospirenone. With continuous dosing, you may not get a monthly period.
- Diuretics which may be useful for women who have significant short-term weight gain from fluid retention.
- Other medicines (such as Depo-Lupron) that suppress the ovaries and ovulation, although the side effects that occur are similar to those occurring in women in menopause.
- Pain relievers such as aspirin or ibuprofen that may be prescribed for headache, backache, menstrual cramps, and breast tenderness.
Most studies have shown that nutritional supplements, such as vitamin B6, calcium, and magnesium are not helpful in relieving symptoms.
After proper diagnosis and treatment, most women with PMDD find that their symptoms go away or drop to tolerable levels.
PMDD symptoms may be severe enough to interfere with a woman's daily life. Women with depression may have worse symptoms during the second half of their cycle and may need changes in their medicine.
Some women with PMDD have suicidal thoughts. Suicide in women with depression is more likely to occur during the second half of their menstrual cycle.
PMDD may be associated with eating disorders and smoking.
When to Contact a Medical Professional
If you or someone you know is thinking about suicide, call or text 988 or chat 988lifeline.org. You can also call 1-800-273-8255 (1-800-273-TALK). The 988 Suicide and Crisis Lifeline provides free and confidential support 24/7, anytime day or night. You can also call 911 or the local emergency number or go to the hospital emergency room. DO NOT delay.
If someone you know has attempted suicide, call 911 or the local emergency number right away. DO NOT leave the person alone, even after you have called for help.
Contact your provider if:
- Symptoms do not improve with self-treatment
- Symptoms interfere with your daily life
PMDD; Severe PMS; Menstrual disorder - dysphoric
Baker FC, McCartney CR. The menstrual cycle, sleep, and circadian rhythms. In: Kryger M, Roth T, Goldstein CA, Dement WC, eds. Principles and Practice of Sleep Medicine. 7th ed. Philadelphia, PA: Elsevier; 2022:chap 185.
Gambone JC. Menstrual cycle-influenced disorders. In: Hacker NF, Gambone JC, Hobel CJ, eds. Hacker & Moore's Essentials of Obstetrics and Gynecology. 6th ed. Philadelphia, PA: Elsevier; 2016:chap 36.
Ing AM, Novac A. Depressive, bipolar, and related mood disorders. In: Kellerman RD, Rakel DP, Heidelbaugh JJ, Lee EM, eds. Conn's Current Therapy 2023. Philadelphia, PA: Elsevier; 2023:833-843.
Mendiratta V, Lentz GM. Primary and secondary dysmenorrhea, premenstrual syndrome, and premenstrual dysphoric disorder: etiology, diagnosis, management. In: Gershenson DM, Lentz GM, Valea FA, Lobo RA, eds. Comprehensive Gynecology. 8th ed. Philadelphia, PA: Elsevier; 2022:chap 35.
Review Date 11/10/2022
Updated by: John D. Jacobson, MD, Department of Obstetrics and Gynecology, Loma Linda University School of Medicine, Loma Linda, CA. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.